Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations.
HCV
asylum seekers
incarcerated people
migrants
psychiatric disorders
refugees
underserved populations
undocumented migrants
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
24 Jul 2023
24 Jul 2023
Historique:
received:
20
06
2023
revised:
18
07
2023
accepted:
21
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Underserved populations have a wide heterogeneity on healthcare provision and use. They also represent the key populations according to WHO 2030 goals for HCV micro-elimination. Our review evaluated the available literature on HCV diagnosis, staging, and treatment among underserved populations, such as incarcerated people, patients with psychiatric disorders, and migrants. A narrative review of literature was performed using key electronic databases (Scopus, Pubmed-MEDLINE) and search engines (Google Scholar). Peer-reviewed publications, grey literature on HCV, and recent models proposed for micro-elimination in underserved populations were included. An insight into the COVID-19 pandemic and its influence on HCV micro-elimination pathways will be also provided. Regarding prison settings, a progressive reduction in HCV epidemiology among incarcerated people in the last years was found (one-third of the level it had been before). People suffering from psychiatric disorders have a high anti-HCV prevalence, but there is a lack of data on active infections. A bidirectional relationship between HCV and psychiatric disorders was found. Migrants showed a very inconsistent assessment of HCV. Furthermore, available studies recorded data from populations with high heterogeneity of anti-HCV prevalence, Therefore, the reported results need caution in their evaluation.
Identifiants
pubmed: 37510549
pii: healthcare11142109
doi: 10.3390/healthcare11142109
pmc: PMC10379370
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Infect Chemother. 2020 Jan;26(1):18-22
pubmed: 31301972
Liver Int. 2021 Feb;41(2):271-275
pubmed: 33226730
J Hepatol. 2008 Oct;49(4):625-33
pubmed: 18706735
Healthcare (Basel). 2021 Sep 09;9(9):
pubmed: 34574960
Infez Med. 2016 Sep 1;24(3):210-6
pubmed: 27668901
Euro Surveill. 2018 Apr;23(16):
pubmed: 29692316
Eur Rev Med Pharmacol Sci. 2012 Dec;16(15):2142-6
pubmed: 23280032
Int J Infect Dis. 2020 Dec;101:126-130
pubmed: 32947054
BMC Public Health. 2013 Oct 20;13:981
pubmed: 24139133
World J Gastroenterol. 2021 Aug 7;27(29):4846-4861
pubmed: 34447230
Clin Pract Epidemiol Ment Health. 2006 Oct 01;2:26
pubmed: 17010216
JHEP Rep. 2021 Mar 18;3(3):100279
pubmed: 34522875
BMC Infect Dis. 2020 Mar 6;20(1):196
pubmed: 32138757
J Infect Dev Ctries. 2021 Mar 07;15(2):297-300
pubmed: 33690214
JAMA. 2013 Dec 25;310(24):2671-2
pubmed: 24368468
Hepatology. 2010 Oct;52(4):1497-505
pubmed: 20635398
Dig Liver Dis. 2022 Jun;54(6):800-804
pubmed: 34649829
Int J Drug Policy. 2018 Sep;59:50-53
pubmed: 29986272
J Viral Hepat. 2020 Dec;27(12):1444-1454
pubmed: 32815623
Hepatology. 2016 Nov;64(5):1821-1822
pubmed: 27118063
Euro Surveill. 2015;20(35):30009
pubmed: 26530499
Front Public Health. 2020 Dec 16;8:596887
pubmed: 33392134
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3935-3943
pubmed: 28975968
BMC Infect Dis. 2022 Jul 7;22(1):601
pubmed: 35799126
Lancet Public Health. 2021 May;6(5):e309-e323
pubmed: 33780656
Int J Drug Policy. 2021 Apr;90:103055
pubmed: 33310637
Life (Basel). 2022 Nov 13;12(11):
pubmed: 36431008
Dig Liver Dis. 2021 Dec;53(12):1603-1609
pubmed: 33893040
J Correct Health Care. 2020 Jul 6;:1078345820929733
pubmed: 32627645
J Infect Dev Ctries. 2021 Jun 30;15(6):847-852
pubmed: 34242196
J Infect Public Health. 2019 Mar - Apr;12(2):200-204
pubmed: 30377049
Med Princ Pract. 2021;30(6):535-541
pubmed: 34818250
Int J Gynaecol Obstet. 2015 Feb;128(2):165-8
pubmed: 25444613
Gut. 2011 Jun;60(6):837-45
pubmed: 21139063
Front Public Health. 2021 Aug 12;9:704520
pubmed: 34458225
Hepatology. 2013 Oct;58(4):1215-24
pubmed: 23504650
BMC Infect Dis. 2012;12 Suppl 2:S2
pubmed: 23173556
Infect Dis Clin North Am. 2018 Jun;32(2):347-370
pubmed: 29778260
Sex Transm Infect. 2023 Feb;99(1):41-46
pubmed: 35351815
J Subst Abuse Treat. 2009 Jul;37(1):32-40
pubmed: 19038524
J Prev Med Hyg. 2020 Oct 06;61(3):E445-E450
pubmed: 33150232
Clin Infect Dis. 2009 Aug 15;49(4):561-73
pubmed: 19589081
J Hepatol. 2020 Nov;73(5):1170-1218
pubmed: 32956768
J Clin Med. 2021 Oct 26;10(21):
pubmed: 34768474
Health Policy. 2021 Mar;125(3):393-405
pubmed: 33461797
BMC Infect Dis. 2014;14 Suppl 5:S2
pubmed: 25236184
Int J Drug Policy. 2018 Jul;57:95-103
pubmed: 29715590
World J Gastroenterol. 2015 Nov 14;21(42):11974-83
pubmed: 26576086
J Psychosom Res. 2007 Mar;62(3):349-55
pubmed: 17324686
Epidemiol Prev. 2011 Sep-Dec;35(5-6):297-306
pubmed: 22166776
Recenti Prog Med. 2013 Dec;104(12):615-8
pubmed: 24362829
Dig Liver Dis. 2022 Feb;54(2):237-242
pubmed: 33926816
J Med Virol. 2005 Jul;76(3):311-7
pubmed: 15902712
Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101852
pubmed: 34923181
Open AIDS J. 2012;6:60-4
pubmed: 22833775
Infez Med. 2017 Mar 1;25(1):57-63
pubmed: 28353457
J Community Health. 2008 Jun;33(3):126-33
pubmed: 18165889
Dig Liver Dis. 2020 May;52(5):541-546
pubmed: 32234417
Front Public Health. 2020 Sep 17;8:559135
pubmed: 33042953
Gastroenterol Hepatol. 2023 May;46(5):382-396
pubmed: 35718017